Europe Syringe Infusion Pump Market To Reach $729.5 Million By 2030

Europe Syringe Infusion Pump Market Growth & Trends

The Europe syringe infusion pump market size is anticipated to reach USD 729.5 million by 2030 and is projected to grow at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of preterm births, the rising prevalence of chronic diseases, and healthcare providers' focus on incorporating advanced technology-driven equipment are leading to growth in the adoption of syringe infusion pumps in Europe.

Growing new cases of cancer, a significant increase in patients diagnosed with diabetes, and continuous growth in patients admitted to intensive care units for treatments associated with complex health conditions are expected to generate growth for this market. The launch of innovation-based products with key features such as real-time monitoring and control devices is expected to drive growth and adoption across hospitals and healthcare facilities.

Significant advancements driven by innovation, research-based product developments, and stringent regulatory requirements regarding the safety and quality of medical devices and equipment are expected to influence this market positively. The rising adoption of controlled delivery of medications and precision dosing in critical care applications is anticipated to create lucrative growth opportunities over the forecast period.

 Request a free sample copy or view report summary: Europe Syringe Infusion Pump Market Report

Europe Syringe Infusion Pump Market Report Highlights

• Based on disease type, the pediatrics/neonatology segment led the market with the largest revenue share of 26.2% in 2024, owing to the significant assistance of syringe infusion pumps in controlled drug delivery while treating newborns and advanced technological capabilities.

• The chemotherapy segment is projected to experience at the fastest CAGR over the forecast period.

• The increasing incidence of chronic disease, primarily cancer, and the growing integration of palliative care with cancer treatments fuel the market growth.

• Based on end use, the hospitals segment accounted for the largest market revenue share in 2024, owing to their increasing application in multiple treatments that require precision dosing and controlled drug delivery.

• The home care segment is projected to grow at the fastest CAGR from 2025 to 2030

• Germany dominated the market with the largest revenue share in 2024, with multiple manufacturers and growing applications in intensive and critical care, chemotherapy, pain management, and other areas. 

Europe Syringe Infusion Pumps Market Segmentation

Grand View Research has segmented the Europe syringe infusion pumps market based on the disease indication, end use, and country:

Europe Syringe Infusion Pump Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Chemotherapy

• Diabetes

• Gastroenterology

• Analgesia/Pain management

• Pediatrics/Neonatology

• Hematology

• Others

Europe Syringe Infusion Pump End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Homecare

• Others (ASC, nursing homes, rehabilitation centers)

Europe Syringe Infusion Pump Country Outlook (Revenue, USD Million, 2018 - 2030)

• Germany

• UK

• France

• Italy

• Spain

• Denmark

• Norway

• Sweden 

List of Key Players in Europe Syringe Infusion Pump Market

• B. Braun SE

• Baxter

• BD

• Fresenius Kabi AG

• Micrel Medical Devices SA

• CODAN Companies

• Arcomed

• ICU Medical, Inc. (Smiths Medical)

• Terumo Corporation

• Moog Inc.